• Loading stock data...
Est. 2004

LEVERAGE OUR MASSIVE INVESTOR AUDIENCE!

Stock Investors · Accredited Investors · Hedge Fund Investors

Learn More

Thursday 04/26/2018
SMALL CAP MARKET NEWS

We release small market news updates daily, 5 times a week! Always check back to get the inside scoop on what going on.


LEVERAGE OUR MASSIVE INVESTOR AUDIENCE!

Stock Investors · Accredited Investors · Hedge Fund Investors

Learn More

biotech

  • 12:48 PM

    Doral, Nov. 07, 2017, ETST, (GLOBE NEWSWIRE) —  Earth Science Tech, Inc. (OTC PINK: ETST) (“ETST” or “the Company”), an innovative biotech company that operates in the fields of hemp cannabinoid (CBD), nutraceutical, pharmaceutical, medical device, research and development, initiates audit process through BF Borgers CPA PC to up-list to the OTCQB Market. ETST’s key factor to up-listing to the OTCQB is to expand its shareholder base and comply to engaged institution funders. BF Borgers has commenced the audit process

    Read more
  • 12:23 PM

    Apr 11, 2017, ETST OTC Disclosure & News Service – Hollywood, April 11, 2017 (GLOBE NEWSWIRE) — Earth Science Tech, Inc. (OTC:ETST OTCBB:ETST $ETST OTC PINK:ETST) (“ETST” or “the Company”), an innovative biotech company focused on cannabis (industrial hemp) and cannabinoid research and development, nutraceuticals, pharmaceuticals, and medical devices, and its two subsidiaries Earth Science Pharmaceutical Inc. and Cannabis Therapeutics Inc., are proud to announce that they will be targeting breast cancer and other women’s health issues with their latest

    Read more
  • 3:22 PM

    REDONDO BEACH, CA–(Marketwired – Nov 21, 2016) – SECFilings.com, a leading financial news and information portal offering free real time public company filing alerts, announces an article covering Pressure BioSciences Inc.’s (OTCQB: PBIO) recently announced financial results, how these record results were achieved, and where the company is headed in the near future. Pressure BioSciences recorded record product and service revenue that increased 4% to $500,949 during the third quarter driven by a 13% increase in instrument sales. At the

    Read more
  • 5:45 PM

    KEEGO HARBOR, MI–ZIVO, (Marketwired – Nov 2, 2016) – ZIVO Bioscience, Inc. (OTCQB: ZIVO) announces today that from July 1, 2016 to date, the Company has received $2 million in new capital funding as part of its Q3/Q4 capital funding initiative. This brings the total of new funding to $3.25 million year to date. In related news, the ZIVO Board of Directors recently approved an increase in the available credit line from HEP Investments, LLC to $17.5 million. To accommodate

    Read more
  • 2:29 PM

    Company Introduces Its Latest Innovation in Regenerative Treatment Solutions SALT LAKE CITY, UT — PRED, (Marketwired) — Predictive Technology Group, Inc. (OTC PINK: PRED), announces that its wholly-owned subsidiary, Predictive Biotech, Inc. has finalized the development process of a new allograft stem cell product derived from umbilical cord blood(UCB). The use of UCB stem cells have gained popularity in medical science owing to their ability to transform into any type of human cells. UCB refers to the blood and tissue

    Read more
Public Wire Banner